LANCL2 and breast adenocarcinoma: Overexpression of LANCL2 in MDA-468 cells was documented by microarray profile analysis, by RT-PCR and by measuring [3H]ABA binding to intact cells, in comparison with the MDA-MB-231 (a breast adenocarcinoma cell line not overexpressing LANCL2)32.